ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Analyst Ratings
Canada - Toronto Stock Exchange - TSX:AND - CA0342231077 - Common Stock
54.97 CAD
+0.01 (+0.02%)
ChartMill assigns a Buy % Consensus number of 50% to AND.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 56.92. This target is 3.54% above the current price.
- AND.CA was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about AND.CA.
- In the previous month the buy percentage consensus was at a similar level.
- AND.CA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-06 | TD Cowen | Maintains | Buy -> Buy |
| 2022-11-10 | RBC Royalbank | Upgrade | Sector Perform |
| 2022-11-10 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-11-10 | TD Research | Upgrade | Hold |
| 2022-11-10 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-11-09 | CIBC Capital Markets | Maintains | Neutral |
| 2022-09-23 | CIBC Capital Markets | Maintains | Neutral |
| 2022-08-11 | Stifel Nicolaus Research | Upgrade | |
| 2022-08-11 | RBC Royalbank | Upgrade | Sector Perform |
| 2022-08-11 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-08-11 | TD Research | Upgrade | Hold |
| 2022-08-11 | CIBC Capital Markets | Upgrade | Neutral |
| 2022-08-10 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-07-12 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-06-03 | CIBC Capital Markets | Downgrade | Neutral |
| 2022-05-06 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-05-06 | National Bank of Canada Financial | Upgrade | Sector Perform |
| 2022-05-06 | TD Research | Downgrade | Hold |
| 2022-05-05 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-03-07 | TD Research | Upgrade | Hold |
| 2022-03-04 | RBC Royalbank | Downgrade | Hold |
| 2022-03-04 | National Bank of Canada Financial | Upgrade | Sector Perform |
| 2022-03-04 | Scotiabank Capital | Upgrade | Sector Perform |
| 2022-03-03 | CIBC Capital Markets | Maintains | Neutral |
| 2022-02-10 | CIBC Capital Markets | Maintains | Neutral |
| 2022-01-18 | RBC Royalbank | Initiate | Hold |
| 2022-01-05 | TD Research | Downgrade | Hold |
| 2021-11-15 | ScotiaBankFinancial | Upgrade | Sector Perform |
| 2021-11-12 | RBCRoyalBank | Upgrade | Outperform |
| 2021-11-12 | TDNewcrest | Upgrade | Buy |
ANDLAUER HEALTHCARE GROUP IN / AND.CA FAQ
What is the average price target for ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
10 analysts have analysed AND.CA and the average price target is 56.92 CAD. This implies a price increase of 3.54% is expected in the next year compared to the current price of 54.97.
What is the consensus rating for ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
The consensus rating for ANDLAUER HEALTHCARE GROUP IN (AND.CA) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.